Trial intelligence / Profile preview

Multiomics of Headache Resistance

NCT04218760Completed

Sponsor
Dansk Hovedpinecenter
Start
Oct 2019
Primary completion
Mar 2020
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of isosorbide mononitrate in Headache, sponsored by Dansk Hovedpinecenter. Primary endpoints: Transcriptomic changes at 5 hours and Metabolomic changes at 5 hours. Started Oct 2019; status: completed.

02

Drugs

isosorbide mononitrate
03

Conditions

Headache

Beyond the preview

Go deeper on NCT04218760.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04218760.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call